736 - Impact of COVID-19 on Mortality Associated with Pseudomonas aeruginosa Bloodstream Infection in the Veterans Health Administration System

Thursday, October 20, 2022

2:00 PM – 2:15 PM US ET

Location: 103 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Presenting Author(s)

Leila S. Hojat, MD, MS

Assistant Professor
Case Western Reserve University/ University Hospitals Cleveland Medical Center
Cleveland, OH, United States

Disclosure: Disclosure(s): No financial relationships to disclose

Slides

Co-Author(s)

BW

Brigid Wilson, PhD

Biostatistician
Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio, United States

Disclosure: Disclosure(s): No financial relationships to disclose
FP

Federico Perez, MD, MS

Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio, United States

Disclosure: Disclosure(s): Accelerate: Grant/Research Support (); Merck: Grant/Research Support (); Pfizer: Grant/Research Support ()
Robert A. Bonomo, MD

Associate Chief of Staff for Academic Affairs
Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center
Cleveland, OH, United States

Disclosure: Disclosure(s): Entasis Pharmaceuticals: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing); NIH VA: Grant/Research Support (Ongoing); VenatoRx Merck Wockhardt Cystic Fibrosis Foundation: Grant/Research Support (Ongoing); Wockhardt: Grant/Research Support (Ongoing)

Disclosure(s):

Leila S. Hojat, MD, MS: No financial relationships to disclose

Brigid Wilson, PhD: No financial relationships to disclose

Federico Perez, MD, MS: Accelerate: Grant/Research Support (); Merck: Grant/Research Support (); Pfizer: Grant/Research Support ()

Robert A. Bonomo, MD: Entasis Pharmaceuticals: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing); NIH VA: Grant/Research Support (Ongoing); VenatoRx Merck Wockhardt Cystic Fibrosis Foundation: Grant/Research Support (Ongoing); Wockhardt: Grant/Research Support (Ongoing)